946121-78-4 Usage
Description
7-Bromo-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine is a heterocyclic chemical compound with the molecular formula C8H7BrN2O. It features a seven-membered ring that includes a nitrogen and oxygen atom, along with a bromine substitution. 7-Bromo-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine may hold potential in medicinal chemistry due to its distinctive structural attributes and possible pharmacological properties. However, further research is required to fully explore its potential applications and implications.
Uses
Used in Medicinal Chemistry:
7-Bromo-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine is used as a compound of interest in medicinal chemistry for its unique structure and potential pharmacological properties. Its specific features may contribute to the development of new drugs or therapeutic agents, although more research is needed to confirm its practical applications and effectiveness.
Check Digit Verification of cas no
The CAS Registry Mumber 946121-78-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,6,1,2 and 1 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 946121-78:
(8*9)+(7*4)+(6*6)+(5*1)+(4*2)+(3*1)+(2*7)+(1*8)=174
174 % 10 = 4
So 946121-78-4 is a valid CAS Registry Number.
946121-78-4Relevant articles and documents
PYRIDO[2,3-B] [1,4] OXAZINES OR TETRAHYDROPYRIDO[2,3-B][1,4] OXAZEPINES AS IAP ANTAGONISTS
-
, (2021/12/31)
Disclosed herein are novel 2,3-dihydro-1H-pyrido[2,3-b][1,4] oxazine or 1,2,3,4-tetrahydropyrido[2,3-b][1,4]oxazepine derivatives used as antagonists of IAPs (Inhibitors Apoptosis Proteins), also known as Smac mimetics. Disclosed herein is the use of these antagonists for inducing or sensitizing cells to the induction of apoptotic cell death, and the use of such compounds for treating proliferative disease such as cancer.
HETEROARYL COMPOUNDS AS INHIBITORS OF NECROSIS, COMPOSITION AND METHOD USING THE SAME
-
, (2019/01/10)
The present disclosure provides heteroaryl compounds of Formula (I), processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of diseases and disorders, arising from or related to necrosis. Formula (I) is shown below:
Novel bicyclic sulfonamide derivatives which are L-CPT1 inhibitors
-
Page/Page column 37, (2010/11/28)
The invention is concerned with novel heterobicyclic derivatives of formula (I) wherein R1, R2, R3, R4, R5, R6, V, W, X and Y are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit L-CPT1 and can be used as medicaments.
